PAKISTAN KIDNEY AND LIVER
INSTITUTE AND RESEARCH CENTER
ACTIVE SURVEILLANCE FORM
1
IPC F0040, Ver:02, ED:26-01-2023
Patient Name: ________________
MR#: _______________________
INVASIVE LINES
Date & Dept
Central line (Site, Insertion &
Removal)
IV Catheter (Site, Insertion &
Removal)
Arterial Catheter (Site, Insertion &
Removal)
ETT (Insertion & Removal)
Foley Catheter
Insertion & Removal
Bed Sore Stage (CA/HAI)
Antimicrobials (Dose & Route)
CLABSI/CRBSI Sign & Symptoms
TLC Or CRP
Temperature (max/Min) last 24 hrs
Observer Name: Gender
(M/F)
Bed/Room # Code status: Date of admission Date of
Discharge
Age: Transferred from: Transferred to Date of transfer
Diagnosis Consultant Name: Any surgery if yes
(specify)
Screen (base line cultures) if any HAI: (Yes/No)
(CLABSI, CAUTI, VAP
Patient status (Alive/Expired)
PAKISTAN KIDNEY AND LIVER
INSTITUTE AND RESEARCH CENTER
ACTIVE SURVEILLANCE FORM
2
IPC F0040, Ver:02, ED:26-01-2023
Patient Name: ________________
MR#: _______________________
Date & Dept
Hypotension (Max/Min) last 24 hrs
Blood/Tip CS
(organism + site)
Phlebitis (stage, CA/HA)
Mucositis (Stage, CA/HA)
CAUTI/UTI Sign & Symptoms
Color of Urine (Pyuria) Y/N
Suprapubic, Tenderness/Pain Y/N
Frequency (Y/N)
Urgency (Y/N)
Dysuria (Y/N)
Urine CS (Organism & site)
VAE/VAP Sign & symptoms
PEEP 0-5>
FIO2 %
New Abx changed
Purulent Respiratory secretions
+ve.
Pleural fluid/biopsy +ve
BAL/tracheal CS +ve

Active Surveillance Form for history .pdf

  • 1.
    PAKISTAN KIDNEY ANDLIVER INSTITUTE AND RESEARCH CENTER ACTIVE SURVEILLANCE FORM 1 IPC F0040, Ver:02, ED:26-01-2023 Patient Name: ________________ MR#: _______________________ INVASIVE LINES Date & Dept Central line (Site, Insertion & Removal) IV Catheter (Site, Insertion & Removal) Arterial Catheter (Site, Insertion & Removal) ETT (Insertion & Removal) Foley Catheter Insertion & Removal Bed Sore Stage (CA/HAI) Antimicrobials (Dose & Route) CLABSI/CRBSI Sign & Symptoms TLC Or CRP Temperature (max/Min) last 24 hrs Observer Name: Gender (M/F) Bed/Room # Code status: Date of admission Date of Discharge Age: Transferred from: Transferred to Date of transfer Diagnosis Consultant Name: Any surgery if yes (specify) Screen (base line cultures) if any HAI: (Yes/No) (CLABSI, CAUTI, VAP Patient status (Alive/Expired)
  • 2.
    PAKISTAN KIDNEY ANDLIVER INSTITUTE AND RESEARCH CENTER ACTIVE SURVEILLANCE FORM 2 IPC F0040, Ver:02, ED:26-01-2023 Patient Name: ________________ MR#: _______________________ Date & Dept Hypotension (Max/Min) last 24 hrs Blood/Tip CS (organism + site) Phlebitis (stage, CA/HA) Mucositis (Stage, CA/HA) CAUTI/UTI Sign & Symptoms Color of Urine (Pyuria) Y/N Suprapubic, Tenderness/Pain Y/N Frequency (Y/N) Urgency (Y/N) Dysuria (Y/N) Urine CS (Organism & site) VAE/VAP Sign & symptoms PEEP 0-5> FIO2 % New Abx changed Purulent Respiratory secretions +ve. Pleural fluid/biopsy +ve BAL/tracheal CS +ve